Patricia Judith Lardone

9PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Foetal development and medicineAnimal welfare
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 18, 2026
Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1).

Ignacio Bejarano, Silvia Jiménez-Jorge, María Ángeles Lobo-Acosta

|Jan 11, 2025
A Lupin (Lupinus angustifolius) Protein Hydrolysate Decreases the Severity of Experimental Autoimmune Encephalomyelitis: A Preliminary Study.

Ivan Cruz-Chamorro, Ana Isabel Álvarez-López, Guillermo Santos-Sánchez

|Dec 31, 2024
Melatonin, an Antitumor Necrosis Factor Therapy.

Ana Isabel Álvarez-López, Ivan Cruz-Chamorro, Patricia Judith Lardone

|Feb 03, 2024
A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice.

Guillermo Santos-Sánchez, Eduardo Ponce-España, Ana Isabel Álvarez-López

|Sep 23, 2022
GPX3 Overexpression in Cumulus Cells Entails a Poor Prognosis for Uterine Implantation of Morphotype A Embryos.

Ignacio Bejarano, Mónica Dorado-Silva, Helia Sarmiento-Soto

|Sep 09, 2022
A Lupin (Lupinusangustifolius) Protein Hydrolysate Exerts Anxiolytic-Like Effects in Western Diet-Fed ApoE-/- Mice.

Guillermo Santos-Sánchez, Eduardo Ponce-España, Juan Carlos López

Pageof 2

Frequent Collaborators

8 joint publications

Antonio Carrillo-Vico

7 joint publications

Ivan Cruz-Chamorro

6 joint publications

Nuria Álvarez-Sánchez

6 joint publications

Guillermo Santos-Sánchez